Philips Seeks to Reduce Time from Heart Attack to Treatment

Royal Philips ElectronicsAt the European Society of Cardiology's (ESC) annual congress, Royal Philips Electronics (NYSE: PHG; AEX: PHI) today demonstrated its HeartStart MRx Monitor/Defibrillator, which enables paramedics to transmit patient data from the ambulance to the hospital's emergency department. Upon reception of the data at the hospital, clinicians can use the ECG data to begin assessing what treatment the incoming patient will need. By allowing a hospital to begin organizing its resources before the patient arrives, the MRx can help reduce the time to treatment.

"As soon as a heart attack occurs, the heart muscle starts to die. That's why reducing the time between heart attack and treatment has been proven to have a big impact on a patient's long-term recovery", commented Joris van den Hurk, vice president of cardiology care cycles for Philips Medical Systems. "As a result, the American College of Cardiology, in partnership with the American Heart Association and other organizations around the world, has launched the 'Door to Balloon' campaign. It aims to reduce the amount of time from the arrival of the patient at the hospital to angioplasty to 90 minutes or less."

In addition to transmitting ECG data to the hospital prior to the patients' arrival, the HeartStart MRx integrates seamlessly with the hospital's ECG management system TraceMasterVue, enabling critical patient information to be seen where it's needed - even in the Catheterization (Cath) Lab.

"With over 17 million people around the world dying from cardiovascular diseases each year, such diseases are the world's number one cause of death," commented Kevin Haydon, EVP and CEO Global Sales & Service International, Philips Medical Systems. "That#s why we're working together with cardiologists to develop technologies that integrate into each part of the cardiac care cycle - from emergency care to diagnosis, treatment and long-term care."

Providing imaging data where it's needed
At ESC 2007, Philips demonstrated several other examples of how it optimizes timely delivery of diagnosis and treatment in the care cycle.

First, the recently introduced ultrasound transducer for Live 3D transesophageal echocardiography (Live 3D TEE) was demonstrated, providing views of cardiac structure and function that are available for the first time. Along with new advanced software for accurate and precise quantification of the mitral valve, surgeons now have valuable data for planning procedures. This TEE probe enables 2D imaging as well as real-time 3D visualization of the heart, in particular the heart's valves, giving clinicians the ability to carry out a complete analysis, which can help achieve a faster and more precise diagnosis.

The exceptional image clarity of Live 3D TEE provides clinical cardiologists, cardiac surgeons, anesthesiologists and echocardiographers with more data, faster. Being able to see accurate, clear images with the push of one button, the need to reconstruct pathology from multiple 2D views is reduced, providing clinicians with more diagnostic information in less time.

Second, Philips showed how it gives surgeons access to scans from imaging equipment which is usually located in different parts of the hospital. Philips CT TrueView software brings high-quality CT data to the Cath Lab, providing clinicians with a more accurate view of the patient's anatomy, and thereby reducing the time from initial diagnosis to treatment.

Redesigning the Cath Lab
A third example of optimization was shown with Philips' Ambient Experience Cath Lab where the entire Cath Lab environment was redesigned to meet the needs of both the patient and surgeon. The innovative design of the suite promotes physical and emotional comfort for the patient and maximizes the interaction between the patient and staff by removing clutter and unnecessary physical barriers often present in a standard suite.

The Ambient Experience suite can help heart patients feel more relaxed during the catheterization procedure by allowing them to personally choose a visual theme viewed on the LCD panels of the ceiling; colored lighting illuminates the walls and sounds represent the theme. Medical staff can also benefit from the features of the Ambient Experience Cath Lab with special diffuse lighting that eliminates any shadows or reflections on monitors. This equal lighting distribution makes the room relaxing and soothing to a physician's eyes.

Physicians also have the ability to check a patient's status before beginning the procedure using a mirror television placed in the preparation room, which helps to save time and allows the physician to immediately focus on the most important person in the room – the patient, thus increasing the human contact. The suite is also equipped with Philips' voice control system, enabling the physician to focus on the patient instead of the system controls.

You can visit Philips at ESC 2007 at the Messe Wien conference centre in Vienna, Austria in Booth A130 from 1st – 5th September 2007.

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 125,800 employees in more than 60 countries worldwide. With sales of $34 billion (EUR 27 billion) in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...